Detection and treatment of early stage prostate cancer. Seminar. USA, 1993/12.
To learn about the natural history of untreated early stage prostatic cancer (stage T0-2NXM0) progression-free, disease specific, overall survival and the need for palliative care were evaluated in a population-based and regionally well defined cohort from Sweden.
Complete followup, with a mean observation of 12.5 years, was achieved in 223 consecutively diagnosed, eligible patients (98%) of all ages.
Patients with progression were hormonally treated (orchiectomy or estrogens) if they had symptoms.
After a mean of 12.5 years only 23 patients (10%) had died of prostate cancer and 125 of 148 deaths (84%) were of other causes.
Mots-clés Pascal : Epithélioma, Prostate, Stade précoce, Oestrogène, Prostatectomie, Suède, Europe, Traitement, Survie, Homme, Mâle, Etude longitudinale, Appareil urinaire pathologie, Prostate pathologie, Appareil génital mâle pathologie, Tumeur maligne, Hormone, Chimiothérapie, Chirurgie
Mots-clés Pascal anglais : Carcinoma, Prostate, Early stage, Estrogen, Prostatectomy, Sweden, Europe, Treatment, Survival, Human, Male, Follow up study, Urinary system disease, Prostate disease, Male genital diseases, Malignant tumor, Hormone, Chemotherapy, Surgery
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0217769
Code Inist : 002B14D02. Création : 09/06/1995.